Clinical Trials Browser

Esophageal Squamous Cell Carcinoma

Carcinoma, Hepatocellular

Resectable Colon Cancer

Pancreatic cancer, adult

Colonic Neoplasms

Rectal Neoplasms

Rectal Neoplasms

Esophageal Neoplasms

Pancreatic Neoplasms

HER2-positive Colorectal Cancer

Carcinoma, Hepatocellular

Esophageal Squamous Cell Carcinoma

Colorectal Neoplasms

Cachexia, Carcinoma, Hepatocellular

Colorectal Neoplasms

PDAC - Pancreatic Ductal Adenocarcinoma

Stomach Neoplasms

Esophageal Neoplasms

Cirrhosis, Familial, with Pulmonary Hypertension, Cholangiocarcinoma

Stomach Neoplasms

Stomach Neoplasms

Colorectal Neoplasms

Pancreatic Neoplasms

Locally Advanced Low Rectal Adenocarcinoma

Appendiceal Neoplasms, Colorectal Neoplasms

Esophageal Neoplasms

Pancreatic Neoplasms

Colorectal Neoplasms

Esophageal Squamous Cell Carcinoma

KRAS G12D-Mutant Advanced or Metastatic Pancreatic Cancer in the First-line Setting

Esophageal Neoplasms

Rectal Neoplasms

Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

Pancreatic Cancer Resectable

Carcinoma, Hepatocellular, Liver Neoplasms, Neoplasm Metastasis

Colorectal Neoplasms

Colonic Neoplasms

Rectal Neoplasms

Peritoneal Neoplasms, Colorectal Neoplasms

Locally Advanced Rectal Cancer

Gastric Cancer Stage

Low Anterior Resection Syndrome, Rectal Neoplasms

Rectal Neoplasms

Carcinoma, Hepatocellular

Colorectal Neoplasms

Colorectal Neoplasms

Neoplasms, Stomach Neoplasms

Biliary Tract Neoplasms, Cholangiocarcinoma

Stomach Neoplasms

Colonic Neoplasms

Clinical Trials

QLC5508 vs. Chemotherapy in Pretreated Advanced or Metastatic Esophageal Squamous Cell Carcinoma

Effects of Neoadjuvant Immunotherapy on Anti-tumour Immunity in Hepatocellular Carcinoma Patients Undergoing Liver Resection

Neoadjuvant/Adjuvant AK104 in Microsatellite Instability-high or Mismatch Repair-deficient, Resectable Colon Cancer

Surufatinib Plus Gemcitabine and Nab-paclitaxel vs. Gemcitabine Plus Nab-paclitaxel in Neoadjuvant Therapy for High - Risk Resectable or Borderline Resectable Pancreatic Cancer

DIAMOND

RECTIL

A Clinical Trial Comparing Long-Course Versus Short-Course Radiotherapy Followed by Immunotherapy Combined With Total Neoadjuvant Therapy (TNT) to Long-Course Radiotherapy Followed by TNT in High-Risk Locally Advanced Rectal Cancer

The Value of Near-Infrared Fluorescence Imaging in the Protection of the Recurrent Laryngeal Nerve During Minimally Invasive Esophagectomy

A Study of FG-M108+Chemotherapy vs Placebo+Chemotherapy in Claudin18.2-positive Pancreatic Cancer

JSKN003 Versus Physician Choiced Treatment in Patients With HER2-positive and Advanced Colorectal Cancer Who Had Failed to Respond to Oxaliplatin, 5-Fu, and Irinotecan

SBRT Versus Surgical Resection for Small HCC

TD-NEOE3V3

Fruquintinib Versus Bevacizumab Plus Chemotherapy in Second-Line RAS-Mutant Metastatic Colorectal Cancer (FRU-RAS)

Nanocrystalline Megestrol Acetate for Cachectic Stage Locally Advanced Hepatocellular Carcinoma

CIRCULATEIII

A Phase III, Randomized, Clinical Trial of GnP Combined With SBRT and Serplulimab Versus GnP as First-Line Treatment for Patients With Recurrent or Metastatic Pancreatic Cancer (WGOG-PAN 006/ICSBR-2)

Robotic vs Laparoscopic Gastrectomy for cT4a Gastric Cancer

Application of Toripalimab as Adjuvant Therapy After Esophageal Cancer Surgery: A Multicenter Clinical Trial

Efficacy and Safety of TT-00420 (Tinengotinib) Tablets Versus Chemotherapy in Patients With Advanced Intrahepatic Cholangiocarcinoma Harboring FGFR2 Fusions/Rearrangements or Mutations

SOP-XH-IRB

Combination of Osemitamab (TST001), Pembrolizumab and Chemotherapy as First-line Therapy in Advanced or Metastatic GC/GEJ Adenocarcinoma

PACHA-02

PTCA199-16

PD-1 + FOLFOXIRI vs CAPOX as Total Neoadjuvant Therapy for pMMR Low Rectal Cancer

Pressurized Intraperitoneal Aerosolized Chemotherapy With Mitomycin for the Treatment of Unresectable Appendix or Colorectal Cancer With Peritoneal Metastases, The IMPACT Trial

MRD2START

Phase III Study to Compare GFH375 and Chemotherapy in Patients With KRAS G12D-Mutant Metastatic Pancreatic Cancer

FOXHIPECT4

Stratified Treatment in Unresectable Locally Advanced ESCC Without Progression After Chemoimmunotherapy Induction Plus CCRT: Toripalimab Consolidation vs observation--a Prospective, Randomized, Controlled Phase III Multicenter Study

HRS 4642 Injection Combined With AG Versus Placebo Combined With AG Therapy in First-Line Advanced or Metastatic Pancreatic Cancer

Patient-Reported Symptom Care Versus Usual Care After Esophageal Cancer Surgery: A Single-Center Phase 3 Randomized Trial

REACT

EC-CRT-008

LEFT-PANC

A Study of TPST-1120 With Atezolizumab Plus Bevacizumab in Patients With Unresectable or Metastatic HCC Not Previously Treated With Systemic Therapy

The Study of JMT101 Combined With Irinotecan as a ≥3rd-Line Treatment in Metastatic Colorectal Cancer

Neoadjuvant CAPOX Plus Tislelizumab vs CAPOX in MSS High-Risk Locally Advanced Colon Cancer

Neoadjuvant Chemoradiotherapy Followed by Chemotherapy With or Without Tislelizumab for Resectable Ultra-low Rectal Cancer: The RELIEVE-02 Study

PROPAC

CinClare-2

Perioperative Tislelizumab Plus Chemotherapy Versus Chemotherapy Alone in MHC-II-Positive Gastric/GEJ Cancer

iRECOVER

Neoadjuvant Radiotherapy for Rectal Adenocarcinoma With Capecitabine Versus TAS-102 (Neo-REACT): A Multi-center, Randomized, Phase III Trial

DARTS

QL1706 Injection Plus Bevacizumab and XELOX vs Placebo Plus Bevacizumab and XELOX as First-Line Treatment of Unresectable Metastatic Colorectal Cancer

FIRE-11

BYQoL-GC

D07001 Softgel-Capsules and Capecitabine Combination Therapy in Patients With Advanced Biliary Tract Cancer

A Study of Disitamab Vedotin Combined With Tislelizumab and Chemotherapy Versus Tislelizumab Combined With Chemotherapy in HER2-Low Advanced Gastric or Gastroesophageal Junction Adenocarcinoma

Pre-Operative Treatment in REseCTable COlon CanceR